Has Lorlatinib/lorlatinib (Lorlatinib) targeted drug been included in medical insurance?
Lorlatinib/Lorlatinib was released in201811 menstruation in the United States FDA has been approved for marketing and will be launched in China in April 2022. It is currently included in medical insurance. Lorlatinib is an oral ATPcompetitive receptor tyrosine kinase, anaplastic lymphoma kinase (ALK) and C-ros oncogene1 with potential anti-tumor activity. (Ros1)Inhibitors are of great significance for the treatment of patients with metastatic non-small cell lung cancer.

Some drugs can have unwanted or dangerous effects when used withlorlatinib/lorlatinib Tell your doctor about all the drugs you are taking and any drugs you start or stop using. Before taking it, tell your doctor if you have heart problems, such as"AV block" (unless you have a pacemaker); lung disease, breathing problems; liver disease, or high cholesterol or triglycerides to make sure it is safe for you to take. Do not uselorlatinib ifthe patientis pregnant. Patients may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while taking this drug and for at least 6 months after the last dose. Ifthe patient is male and if the partner is able to become pregnant, use effective contraceptive measures and continue to use birth control pills for at least3 months after the last dose. While taking this medication, do not breastfeed for at least 7 days after the last dose.
Sometimes it is unsafe to use certain drugs together Some drugs can affect the blood levels of other drugs you take, which may increase side effects or make the drugs less effective. Many drugs can interact with lorlatinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Generic lorlatinib has been launched in Laos and Bangladesh, with each box costing about 3more than a thousand5About a thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)